The assay can track either the disappearance of an intact protein or peptide substrate or the appearance of products generated by cleavage. These readouts provide complementary ways to quantify proteolysis, but their signal must be interpreted according to the selected substrate and detection method. Color or fluorescence changes therefore indicate enzyme activity through different measurable consequences of degradation.
pH, temperature, inhibitors, and protease mutations can alter the measured activity. Each factor may change how effectively the enzyme degrades the defined substrate, allowing researchers to compare functional conditions rather than treating activity as fixed. Holding other conditions controlled is important because differences in the signal should reflect the variable being investigated as closely as possible.
Inhibitors and mutations help connect an observed degradation signal to protease function. Comparing activity with and without an inhibitor can show whether proteolysis is sensitive to that intervention, while comparing variants can reveal functional differences associated with altered enzyme sequences. These comparisons support the study of enzyme regulation and the molecular basis of protein degradation pathways.
A typical workflow selects a defined protein or peptide substrate, combines it with the protease, and incubates the reaction under controlled conditions. Researchers then quantify substrate loss or cleavage-product formation using a color or fluorescence readout. Comparing signals across conditions, such as different pH values, temperatures, inhibitors, or protease variants, provides a structured measure of relative proteolytic activity.
Researchers use the assay when they need a direct, measurable comparison of protease activity. It can show how strongly different enzymes or variants degrade a substrate and how experimental conditions modify that function. This quantitative approach supports investigations of digestion, cellular regulation, disease mechanisms, biotechnology, and drug development by linking a controlled measurement to a biological or applied question.
Results can help characterize how protein degradation is regulated and how proteolytic activity changes across experimental conditions. In biology, that information is relevant to digestion and cellular regulation, while disease studies can examine altered degradation mechanisms. The same measurements also provide a basis for biotechnology and drug development studies that compare enzyme behavior or evaluate effects on protease function.